GlassScriptPhysician profile
Anthony Disciullo
NPI 1972573913
$7,556.22
in general payments reported to CMS, 2019-2025
27 companies · $546 in 2025
The $546 reported for 2025 was more than what 77% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,054 · 2020: $263 · 2021: $862 · 2022: $1,286 · 2023: $1,499 · 2024: $1,046 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,091.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,073.50 | 2019-2025 | Altis, Saffron |
| Intuitive Surgical, INC. | $807.02 | 2019 | |
| Axonics, INC. | $736.51 | 2022-2024 | Bulkamid, Axonics |
| Abbvie INC. | $635.44 | 2019-2025 | Botox |
| Astellas Pharma US INC | $574.60 | 2019-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $525.29 | 2019-2023 | Coolseal Generator |
| Medtronic, INC. | $435.40 | 2021-2025 | Interstim |
| Pfizer INC. | $430.76 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $331.78 | 2023-2025 | Gemtesa, Myfembree |
| Boston Scientific Corporation | $286.94 | 2020-2025 | Upsylon, Bulkamid |
| Gynesonics, INC. | $279.85 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $264.22 | 2020-2022 | |
| Caldera Medical, INC | $247.27 | 2023-2025 | Desara |
| Therapeuticsmd, INC. | $239.12 | 2019-2021 | |
| Myovant Sciences INC. | $119.97 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urocure LLC | $87.40 | 2021-2022 | |
| Convatec INC. | $72.40 | 2022-2024 | |
| Renovia INC | $72.20 | 2019 | |
| Minerva Surgical, INC | $72.11 | 2021-2024 | |
| Coopersurgical, INC. | $51.77 | 2020 | |
| Urovant Sciences INC | $49.39 | 2021-2022 | |
| Aesculap, INC. | $40.42 | 2019 | |
| Ethicon US, LLC | $36.86 | 2020 | |
| Medtronic USA, INC. | $30.25 | 2019 | |
| Rochester Medical Corporation | $24.15 | 2021 | |
| Lupin INC. | $17.19 | 2019 | |
| Metuchen Pharmaceuticals | $14.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Disciullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.